Janet Woodcock continues to purge the word review from the Center for Drug Evaluation and Research, favoring the word assessment to characterize the new drug application clearance process.
Vocabulary Change: CDER Eliminating 'Review' For NDAs And BLAs
Like ANDA evaluations, US FDA plans to use the word assessment to describe them for NDAs and BLAs.
